Wire · opportunities
Tempus Secures Up To $9.5 Million From ARPA-H To Develop Autonomous AI Agent For ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 September 2026 · Fusion42 review
Tempus AI received up to $9.5 million from ARPA-H to develop and clinically validate an autonomous AI agent for managing heart failure, aiming to coordinate cardiovascular care without direct human intervention and addressing a critical care gap in the US.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 3 sources have reported it between 11 Sep 2026 and 20 Sep 2026.
◆ ◆ The Wire takeaway
Agentic AI is moving from recommendations to actual patient care coordination in US heart failure. You should explore direct integration of AI agents in chronic care workflows before competitors do.
◆ Coverage
3 sources · first reported 11 Sep 2026 · latest 20 Sep 2026
◆ Related on Wire
◆ Topics